Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Ugeskrift for Laeger
|
October 16, 2019
[Trends in oncological phase I trials]
Kristoffer Staal Rohrberg, Camilla Qvortrup, Martin Højgaard, et al.
Cells
|
July 25, 2025
A High-Throughput ImmunoHistoFluorescence (IHF) Method for Sub-Nuclear Protein Analysis in Tissue
Kezia Catharina Oxe, Kristoffer Staal Rohrberg, Ulrik Lassen, et al.
Ugeskrift for Laeger
|
March 6, 2024
Bue Ross Agner, Caroline Hasselbalch Riley, Søren Lykke Petersen, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 26, 2011
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer
Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen, et al.
BMC Cancer
|
December 16, 2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, et al.
Journal of Cancer Research and Clinical Oncology
|
July 8, 2024
Similar genetic profile in early and late stage urothelial tract cancer
Dag Rune Stormoen, Kristoffer Staal Rohrberg, Kent William Mouw, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
June 6, 2022
Differences in gene expression despite identical histomorphology in sinonasal intestinal-type adenocarcinoma and metastases from colorectal adenocarcinoma
Sannia Sjöstedt, Filipe Garrett Vieira, Kirstine Karnov, et al.
Cancer Genetics
|
May 28, 2025
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, Rigshospitalet
Rosa Damkjær Britton, Daniela Alosi, Luca Robinson, et al.
Cancer Biology & Therapy
|
February 19, 2011
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab
Kristoffer Staal Rohrberg, Helle Pappot, Ulrik Lassen, et al.
British Journal of Cancer
|
June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Ida Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Ugeskrift for Laeger
|
October 16, 2019
[Trends in oncological phase I trials]
Kristoffer Staal Rohrberg, Camilla Qvortrup, Martin Højgaard, et al.
Cells
|
July 25, 2025
A High-Throughput ImmunoHistoFluorescence (IHF) Method for Sub-Nuclear Protein Analysis in Tissue
Kezia Catharina Oxe, Kristoffer Staal Rohrberg, Ulrik Lassen, et al.
Ugeskrift for Laeger
|
March 6, 2024
Bue Ross Agner, Caroline Hasselbalch Riley, Søren Lykke Petersen, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 26, 2011
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer
Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen, et al.
BMC Cancer
|
December 16, 2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, et al.
Journal of Cancer Research and Clinical Oncology
|
July 8, 2024
Similar genetic profile in early and late stage urothelial tract cancer
Dag Rune Stormoen, Kristoffer Staal Rohrberg, Kent William Mouw, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
June 6, 2022
Differences in gene expression despite identical histomorphology in sinonasal intestinal-type adenocarcinoma and metastases from colorectal adenocarcinoma
Sannia Sjöstedt, Filipe Garrett Vieira, Kirstine Karnov, et al.
Cancer Genetics
|
May 28, 2025
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, Rigshospitalet
Rosa Damkjær Britton, Daniela Alosi, Luca Robinson, et al.
Cancer Biology & Therapy
|
February 19, 2011
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab
Kristoffer Staal Rohrberg, Helle Pappot, Ulrik Lassen, et al.
British Journal of Cancer
|
June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Ida Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Page
of 3